Lisa Carson

Executive Officer at Phio Pharmaceuticals.

Earliest Form D on file: Aug 2025

2 filings at 1 company

Phio Pharmaceuticals

Biotech, Marlborough MA

Executive Officer

Biotech, Marlborough MA

Signed
Named
Size is amount sold, up to $30M

Filings

2

Nov 12, 2025
Option to acquire, security to be acquired, named · Form D
$1.4M
of $25.9M
Nov 12, 2025
Option to acquire, security to be acquired
Named, Executive Officer
$1.4M
$25.9M
Form D
Aug 4, 2025
Option to acquire, security to be acquired, named · Form D
$232K
of $5.1M
Aug 4, 2025
Option to acquire, security to be acquired
Named, Executive Officer
$232K
$5.1M
Form D

Network

At Phio Pharmaceuticals

7 people

Robert J. Bitterman
Together on 2 filings
Director, Executive Officer, signed as President and Chief Executive Officer
Curtis Lockshin, Ph.D.
Together on 2 filings
Director
David Deming
Together on 2 filings
Director
Jonathan Freeman
Together on 2 filings
Director
Patricia A. Bradford
Together on 2 filings
Director
Robert Ferrara
Together on 1 filing
Director

1 more at Phio Pharmaceuticals